News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
Roche’s Tamiflu Gets EU Approval For Use On Children
January 31, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Tamiflu, the anti-influenza drug being stockpiled around the world as a potential defence against bird flu, has received approval to be used for children aged one to twelve in the European Union.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Europe
Roche
MORE ON THIS TOPIC
Approvals
GSK, Ionis win FDA nod for hepatitis B functional cure that controls virus after treatment
October 21, 2026
·
3 min read
·
Tristan Manalac
Manufacturing
Sanofi breaks ground on insulin plant after securing German government support
October 19, 2026
·
2 min read
·
Nick Paul Taylor
Manufacturing
FDA issues warning over Eurofins’ selective recording that ‘compromises’ data
October 16, 2026
·
2 min read
·
Nick Paul Taylor
FDA
FDA’s latest rare disease framework seeks to prioritize consistency in flexibility
October 15, 2026
·
4 min read
·
Michael Gibney